Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Obstet Gynecol Int ; 2024: 5520312, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38779127

RESUMO

Objective: Validate the full-PIERS model in predicting adverse maternal outcomes in women with early-onset preeclampsia with severe features in our population. Methods: Retrospective cohort study. We applied the full-PIERS model on 130 women with severe early-onset preeclampsia who were treated at a second-level hospital in Nuevo León, México. We validated the full-PIERS model in its ability to discriminate through the AUROC. Results: The full-PIERS model applied to the data obtained in our study had good discrimination, revealing an AUC of 0.718 (95% CI 0.515-0.921; P = 0.017). A cut-off of 7.95 was identified as the cut-off point with the best diagnostic performance, with the highest Youden index, presenting a sensitivity of 54.5% and specificity of 99.2% for the development of complications. Conclusion: The full-PIERS model can predict adverse maternal outcomes in women admitted to our hospital with severe early-onset preeclampsia within 48 hours of admission.

2.
Am J Trop Med Hyg ; 110(2): 320-322, 2024 Feb 07.
Artigo em Inglês | MEDLINE | ID: mdl-38190746

RESUMO

Rocky Mountain spotted fever (RMSF) is a tick-borne infection caused by Rickettsia rickettsii. We present a series of two cases of pregnant patients who showed up at the emergency room of a hospital in Nuevo León, Mexico. Both patients lived in environments where R. rickettsii is endemic and they presented with several days of symptoms, including fever. Both patients developed a rash and had stillbirths during their hospital stay. Treatment with doxycycline was delayed, with fatal results in both patients. Diagnosis of RMSF was confirmed via polymerase chain reaction assay postmortem. The need to link epidemiological clues with clinical data is critical in the diagnosis and early treatment of RMSF to prevent maternal deaths.


Assuntos
Infecções por Rickettsia , Febre Maculosa das Montanhas Rochosas , Humanos , Gravidez , Feminino , Febre Maculosa das Montanhas Rochosas/diagnóstico , Febre Maculosa das Montanhas Rochosas/tratamento farmacológico , Febre Maculosa das Montanhas Rochosas/epidemiologia , Infecções por Rickettsia/diagnóstico , Infecções por Rickettsia/tratamento farmacológico , Rickettsia rickettsii , Doxiciclina/uso terapêutico , México/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA